Uncertainties in assesment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator

被引:54
作者
Berger, Daniel [1 ]
Dimopoulos, Johannes [1 ]
Georg, Petra [1 ]
Georg, Dietmar [1 ]
Poetter, Richard [1 ]
Kirisits, Christian [1 ]
机构
[1] Med Univ Vienna, Dept Radiotherapy & Radiobiol, AKH, A-1090 Vienna, Austria
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 67卷 / 05期
关键词
brachytherapy; vaginal dose; tandem ring applicator; cervical cancer;
D O I
10.1016/j.ijrobp.2006.11.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The vagina has not been widely recognized as organ at risk in brachytherapy for cervical cancer. No widely accepted dose parameters are available. This study analyzes the uncertainties in dose reporting for the vaginal wall using tandem-ring applicators. Methods and Materials: Organ wall contours were delineated on axial magnetic resonance (MR) slices to perform dose-volume histogram (DVH) analysis. Different DVH parameters were used in a feasibility study based on 40 magnetic resonance imaging (MRI)-based treatment plans of different cervical cancer patients. Dose to the most irradiated, 0.1 cm(3), 1 cm(3), 2 cm(3), and at defined points on the ring surface and at 5-mm tissue depth were reported. Treatment-planning systems allow different methods of dose point definition. Film dosimetry was used to verify the maximum dose at the surface of the ring applicator in an experimental setup. Results: Dose reporting for the vagina is extremely sensitive to geometrical uncertainties with variations of 25% for 1 mm shifts. Accurate delineation of the vaginal wall is limited by the finite pixel size of MRI and available treatment-planning systems. No significant correlation was found between dose-point and dose-volume parameters. The DVH parameters were often related to noncontiguous volumes and were not able to detect very different situations of spatial dose distributions inside the vaginal wall. Deviations between measured and calculated doses were up to 21%. Conclusions: Reporting either point dose values or DVH parameters for the vaginal wall is based on high inaccuracies because of contouring and geometric positioning. Therefore, the use of prospective dose constraints for individual treatment plans is not to be recommended at present. However, for large patient groups treated within one protocol correlation with vaginal morbidity can be evaluated. (c) 2007 Elsevier Inc.
引用
收藏
页码:1451 / 1459
页数:9
相关论文
共 22 条
[1]  
[Anonymous], 1980, TXB RADIOTHERAPY
[2]   The irradiation tolerance dose of the proximal vagina [J].
Au, SP ;
Grigsby, PW .
RADIOTHERAPY AND ONCOLOGY, 2003, 67 (01) :77-85
[3]   Cervical brachytherapy utilizing ring applicator: Comparison of standard and conformal loading [J].
Brooks, S ;
Bownes, P ;
Lowe, G ;
Bryant, L ;
Hoskin, PJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03) :934-939
[4]   VAGINAL STENOSIS AND SEXUAL FUNCTION FOLLOWING INTRACAVITARY RADIATION FOR THE TREATMENT OF CERVICAL AND ENDOMETRIAL CARCINOMA [J].
BRUNER, DW ;
LANCIANO, R ;
KEEGAN, M ;
CORN, B ;
MARTIN, E ;
HANKS, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (04) :825-830
[5]   Systematic evaluation of MRI findings in different stages of treatment of cervical cancer:: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk [J].
Dimopoulos, JCA ;
Schard, G ;
Berger, D ;
Lang, S ;
Goldner, G ;
Helbich, T ;
Pötter, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (05) :1380-1388
[6]   Determination of the accuracy of implant reconstruction and dose delivery in brachytherapy in The Netherlands and Belgium [J].
Elfrink, RJM ;
Kolkman-Deurloo, IKK ;
van Kleffens, HJ ;
Rijnders, A ;
Schaeken, B ;
Aalbers, THL ;
Dries, WJF ;
Venselaar, JLM .
RADIOTHERAPY AND ONCOLOGY, 2001, 59 (03) :297-306
[7]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV [J].
Haie-Meder, C ;
Pötter, R ;
Van Limbergen, E ;
Briot, E ;
De Brabandere, M ;
Dimopoulos, J ;
Dumas, I ;
Hellebust, TP ;
Kirisits, C ;
Lang, SF ;
Muschitz, S ;
Nevinson, J ;
Nulens, A ;
Petrow, P ;
Wachter-Gerstner, N .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :235-245
[8]   AN ANALYSIS OF THE EFFICACY AND SAFETY OF HIGH-DOSE-RATE AS COMPARED TO LOW-DOSE RATE BRACHYTHERAPY IN THE TREATMENT OF UTERINE CERVICAL-CARCINOMA [J].
HARTMANN, TJ ;
SARKARIA, JN ;
PETEREIT, DG ;
STITT, JA ;
BUCHLER, DA ;
CHAPPELL, R ;
FOWLER, JF ;
KINSELLA, TJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 :130-130
[9]   RADIATION TOLERANCE OF THE VAGINAL MUCOSA [J].
HINTZ, BL ;
KAGAN, AR ;
CHAN, P ;
GILBERT, HA ;
NUSSBAUM, H ;
RAO, AR ;
WOLLIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (06) :711-716
[10]  
Holloway CL, 2006, BRACHYTHERAPY, V5, P82